Annis Gardner Whiting Capital Advisors’s Hologic HOLX Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-220	Closed	-$16.6K	–	733
2026 Q1	$16.6K	Buy	220 +67	+44%	+$5.04K	﹤0.01%	783
2025 Q4	$11.4K	Buy	153 +15	+11%	+$1.1K	﹤0.01%	754
2025 Q3	$9.31K	Buy	138 +9	+7%	+$597	﹤0.01%	719
2025 Q2	$8.41K	Hold	129	–	–	﹤0.01%	761
2025 Q1	$7.97K	Hold	129	–	–	﹤0.01%	571
2024 Q4	$9.3K	Hold	129	–	–	﹤0.01%	540
2024 Q3	$10.5K	Hold	129	–	–	﹤0.01%	542
2024 Q2	$9.58K	Hold	129	–	–	﹤0.01%	693
2024 Q1	$10.1K	Buy	129 +2	+2%	+$149	﹤0.01%	670
2023 Q4	$9.07K	Hold	127	–	–	﹤0.01%	488
2023 Q3	$8.81K	Buy	+127	New	+$9.6K	﹤0.01%	477

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's HOLX Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 220 shares — an estimated $16.6K sold.

Annis Gardner Whiting Capital Advisors first reported a position in HOLX in Q3 2023 and held it in 11 quarters. The position peaked at $16.6K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Annis Gardner Whiting Capital Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Annis Gardner Whiting Capital Advisors sold 220 Hologic shares in Q2 2026, an estimated $16.6K.
Annis Gardner Whiting Capital Advisors first reported a position in Hologic in Q3 2023 and held it in 11 quarters.
Annis Gardner Whiting Capital Advisors's Hologic position peaked at $16.6K in Q1 2026.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.